BlackRock’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,544,947
| Closed | -$53.6M | – | 5947 |
|
|
2022
Q3 | $53.6M | Buy |
3,544,947
+113,177
| +3% | +$1.32M | ﹤0.01% | 2384 |
|
|
2022
Q2 | $25.7M | Buy |
3,431,770
+118,764
| +4% | +$837K | ﹤0.01% | 2946 |
|
|
2022
Q1 | $30.1M | Sell |
3,313,006
-73,009
| -2% | -$563K | ﹤0.01% | 2908 |
|
|
2021
Q4 | $23.8M | Sell |
3,386,015
-37,652
| -1% | -$394K | ﹤0.01% | 3176 |
|
|
2021
Q3 | $39M | Buy |
3,423,667
+91,258
| +3% | +$1.33M | ﹤0.01% | 2827 |
|
|
2021
Q2 | $53.4M | Sell |
3,332,409
-231,560
| -6% | -$3.97M | ﹤0.01% | 2657 |
|
|
2021
Q1 | $63.7M | Sell |
3,563,969
-328,272
| -8% | -$5.67M | ﹤0.01% | 2469 |
|
|
2020
Q4 | $52.6M | Buy |
3,892,241
+194,130
| +5% | +$2.35M | ﹤0.01% | 2438 |
|
|
2020
Q3 | $43.5M | Sell |
3,698,111
-138,473
| -4% | -$1.69M | ﹤0.01% | 2380 |
|
|
2020
Q2 | $56.6M | Buy |
3,836,584
+350,392
| +10% | +$5.18M | ﹤0.01% | 2180 |
|
|
2020
Q1 | $47.1M | Buy |
3,486,192
+3,980
| +0.1% | +$75.5K | ﹤0.01% | 2084 |
|
|
2019
Q4 | $84.2M | Sell |
3,482,212
-195,822
| -5% | -$4.06M | ﹤0.01% | 2057 |
|
|
2019
Q3 | $70.7M | Buy |
3,678,034
+319,133
| +10% | +$7.31M | ﹤0.01% | 2085 |
|
|
2019
Q2 | $99.3M | Buy |
3,358,901
+331,884
| +11% | +$12.8M | ﹤0.01% | 1918 |
|
|
2019
Q1 | $144M | Sell |
3,027,017
-181,928
| -6% | -$8.01M | 0.01% | 1651 |
|
|
2018
Q4 | $116M | Buy |
3,208,945
+84,605
| +3% | +$3.97M | 0.01% | 1693 |
|
|
2018
Q3 | $192M | Buy |
3,124,340
+133,239
| +4% | +$8.57M | 0.01% | 1525 |
|
|
2018
Q2 | $202M | Buy |
2,991,101
+246,686
| +9% | +$13.8M | 0.01% | 1448 |
|
|
2018
Q1 | $149M | Sell |
2,744,415
-40,124
| -1% | -$2.24M | 0.01% | 1572 |
|
|
2017
Q4 | $166M | Sell |
2,784,539
-46,472
| -2% | -$2.82M | 0.01% | 1530 |
|
|
2017
Q3 | $138M | Buy |
2,831,011
+228,187
| +9% | +$12.4M | 0.01% | 1626 |
|
|
2017
Q2 | $137M | Buy |
2,602,824
+1,936
| +0.1% | +$90.1K | 0.01% | 1583 |
|
|
2017
Q1 | $118M | Buy |
2,600,888
+2,598,596
| +113,377% | +$116M | 0.01% | 1665 |
|
|
2016
Q4 | $87K | Buy |
2,292
+156
| +7% | +$5.9K | ﹤0.01% | 2644 |
|
|
2016
Q3 | $81K | Buy |
2,136
+204
| +11% | +$4.5K | ﹤0.01% | 2721 |
|
|
2016
Q2 | $34K | Buy |
1,932
+153
| +9% | +$2.48K | ﹤0.01% | 3099 |
|
|
2016
Q1 | $22K | Buy |
1,779
+1,205
| +210% | +$19.1K | ﹤0.01% | 2815 |
|
|
2015
Q4 | $14K | Sell |
574
-213
| -27% | -$4.97K | ﹤0.01% | 2743 |
|
|
2015
Q3 | $14K | Buy |
787
+500
| +174% | +$9.06K | ﹤0.01% | 2586 |
|
|
2015
Q2 | $5K | Hold |
287
| – | – | ﹤0.01% | 3137 |
|
|
2015
Q1 | $9K | Hold |
287
| – | – | ﹤0.01% | 2808 |
|
|
2014
Q4 | $8K | Hold |
287
| – | – | ﹤0.01% | 2905 |
|
|
2014
Q3 | $6K | Hold |
287
| – | – | ﹤0.01% | 3028 |
|
|
2014
Q2 | $7K | Buy |
+287
| New | +$4.97K | ﹤0.01% | 3022 |
|
BlackRock's AERI Position: Q4 2022 in Review
BlackRock sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 3,544,947 shares — an estimated $53.6M sold.
BlackRock first reported a position in AERI in Q2 2014 and held it in 34 quarters. The position peaked at $202M in Q2 2018. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- BlackRock reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- BlackRock sold 3,544,947 Aerie Pharmaceuticals shares in Q4 2022, an estimated $53.6M.
- BlackRock first reported a position in Aerie Pharmaceuticals in Q2 2014 and held it in 34 quarters.
- BlackRock's Aerie Pharmaceuticals position peaked at $202M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on BlackRock's 13F filing for Q4 2022, filed 13 Feb 2023.